A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer
about
A founder effect in the newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cMThe p53-estrogen receptor loop in cancerSome aspects of molecular diagnostics in Lynch syndrome.Genetic susceptibility to non-polyposis colorectal cancer.Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.Estrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-β.MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer.Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer.KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patientsRecurrent germline mutation in MSH2 arises frequently de novo.Anticipation in lynch syndrome: where we are where we goAn American founder mutation in MLH1.Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.Estradiol regulates miR-135b and mismatch repair gene expressions via estrogen receptor-β in colorectal cells.A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin.Association between sex hormones and colorectal cancer risk in men and women.Update on Lynch syndrome genomics.Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.
P2860
Q24534402-C90383F7-6D89-4025-9A1B-4A36B9CADE01Q27027865-C00369EE-F8CB-4BFB-8C23-6CA1B9C9FD1BQ33722604-4A09C060-DE7F-4C97-A64D-638ABF59E6C4Q33764029-CB3928B4-46A5-44D6-83D0-BD69AC4E1C6CQ33862850-0C202E39-0BD4-4186-8FF9-F345CC846356Q33888955-E310B3D7-6B12-4250-B2FF-79DD03E5B2A3Q33909800-BA697F11-22C0-4C14-B93F-9A9AE0855053Q33918755-A583836A-1EB3-4E6B-9974-81FFEAC6F093Q34013141-0B0F37E6-35D9-43DF-B47F-78C0DE2F34A1Q35144608-EBF99A82-DD5A-420D-8B75-160F87760184Q35435822-2E9258FB-D016-438B-AA41-B3B7B8FD7259Q35560811-40E08AFA-3AFD-4B25-AC92-6EFCE09BF55EQ35700015-B1AF56F9-6A6D-497C-BC9E-6BE19E024A4CQ36065786-8113A790-DC87-47B2-A767-1396EE648814Q36514437-36A2FF5C-0B40-4162-B100-B46D7E311ABBQ36543031-D7BE3513-185B-4D99-866E-3FDD364810F7Q36675024-B476896D-6A64-4BD2-A8DB-F32D9F8214ADQ36990046-91B445D0-E26F-4BC3-9489-AC87F369C304Q37348461-54678E1B-E9AA-425D-869C-72458FCD34A6Q37417652-302B4027-5978-4BAD-80EA-4F9F68F7C495Q41625837-ECD359F0-D40C-4710-9BC7-38A59B7C535A
P2860
A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A common MSH2 mutation in Engl ...... fferences in colorectal cancer
@ast
A common MSH2 mutation in Engl ...... fferences in colorectal cancer
@en
type
label
A common MSH2 mutation in Engl ...... fferences in colorectal cancer
@ast
A common MSH2 mutation in Engl ...... fferences in colorectal cancer
@en
prefLabel
A common MSH2 mutation in Engl ...... fferences in colorectal cancer
@ast
A common MSH2 mutation in Engl ...... fferences in colorectal cancer
@en
P2093
P2860
P1476
A common MSH2 mutation in Engl ...... fferences in colorectal cancer
@en
P2093
P2860
P304
P407
P577
1999-02-01T00:00:00Z